𝔖 Bobbio Scriptorium

✦ LIBER ✦

An in vitro screening assay for inhibitors of proinflammatory mediators in herbal extracts using human synoviocyte cultures

✍ Scribed by Carmelita G. Frondoza; Afshin Sohrabi; Anna Polotsky; Phong V. Phan; David S. Hungerford; Lars Lindmark

Book ID: 115044859
Publisher: Society for In Vitro Biology
Year: 2004
Tongue: English
Weight: 1012 KB
Volume: 40
Category: Article
ISSN: 1475-2689
DOI: 10.1290/1543-706x(2004)040<0074:pomdvb>2.0.co;2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Screening of River Water for Immunot

The Screening of River Water for Immunotoxicity Using an In Vitro Whole Blood Culture Assay

✍ Edmund J. Pool; Tandeka U. Magcwebeba 📂 Article 📅 2008 🏛 Springer Netherlands 🌐 English ⚖ 164 KB

An in-vitro screening assay for the dete

An in-vitro screening assay for the detection of inhibitors of proinflammatory cytokine synthesis: a useful tool for the development of new antiarthritic and disease modifying drugs

✍ S. Laufer; C. Greim; T. Bertsche 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 310 KB

Establishment of an in vitro assay syste

Establishment of an in vitro assay system for screening hepatitis C virus protease inhibitors using high performance liquid chromatography

✍ Kenji Sudo; Hiroshi Inoue; Yasuaki Shimizu; Kayo Yamaji; Kenji Konno; Shiro Shig 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 809 KB

An in-vitro validation study in the fiel

An in-vitro validation study in the field of toxicokinetics and metabolism: Validation of an LC–MS/MS assay for simultaneous assessment of cytochrome P450 activity using cryopreserved human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, CYP2C9 and CYP1A2

✍ E. Bourgogne; G. Saucez; S. Dell’Aiera; M. rosa; C. Jacques-hespel; B. Gerin; H. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Establishment of an in vitro assay syste

Establishment of an in vitro assay system for screening hepatitis C virus protease inhibitors using high performance liquid chromatography: Kenji Sudo1,3, Hiroshi Inoue1, Yasuaki Shimizu2, Kayo Yamaji2, Kenji Konno1, Shiro Shigeta3, Takashi Kaneko4, Tomoyuki Yokota1, and Kunitada Shimotohno4, Rational Drug Design Laboratories1, Fukushima 960-12, Molecular Medicine Research Laboratories, Yamanouchi Pharmaceutical Co. Ltd.2, Tsukuba-shi, Ibaraki 305, Department of Microbiology, Fukushima Medical College3, Fukushima 960-12, Virology Division, National Cancer Center Research Institute4, Tokyo 104, Japan

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 113 KB